Atlas Trials

Adenosine 2A Receptor Antagonism and AIH in ALS

Clinical trial NCT05377424 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05377424
Sponsor
University of Florida
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
ALS
Start date
2022-06-21
Primary completion
2026-01-26
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.